Feed excerpt — reported by STAT News
Mark Cuban's Cost Plus Drugs seeks to reduce manufacturing costs for custom rare disease drugs and n-of-1 gene therapies with new fill-finish plant in Dallas.
MAP records observable characteristics of the original article (publisher, author, date, references, framing cues). MAP does not verify the article’s claims or score it. Read the full original story at STAT News →